ERITROPOYETINA RECOMBINANTE PDF

Many translated example sentences containing “eritropoyetina recombinante” – English-Spanish dictionary and search engine for English translations. La farmacocinética de la eritropoyetina recombinante humana en pacientes con nefropatía endémica de los Balcanes. The Pharmacokinetics of Recombinant. Efecto del tratamiento con eritropoyetina recombinante humana sobre la necesidad de transfusión sanguínea en los pacientes críticos. Effect of human.

Author: Temi Nikozuru
Country: Bhutan
Language: English (Spanish)
Genre: Spiritual
Published (Last): 14 February 2018
Pages: 399
PDF File Size: 16.22 Mb
ePub File Size: 20.71 Mb
ISBN: 910-3-61704-891-2
Downloads: 67973
Price: Free* [*Free Regsitration Required]
Uploader: Fekora

All works go through a rigorous selection process.

All analyses recombinahte performed using the SPSS ver. Continuing navigation will be considered as acceptance of this use. New indications for erythropoietin in clinical practice. J Clin Pharmacol ; Their main characteristics are presented in Table 1.

Comparison of two recombinant erythropoietin formulations in patients with anemia due to end-stage renal disease on hemodialysis: Blood samples were centrifuged for 10 min and plasma stored frozen until analysis. Pavlovic-Kentera V, Djukanovic Lj. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal’s impact. Analysis of covariance ANCOVA was used to adjust these differences for patient characteristics that differed between groups: Further information Always consult your healthcare provider to ensure reocmbinante information displayed on this page applies to your personal circumstances.

Conflicts of interest The authors declare that they have no conflicts of interest related to the contents of this article.

Statistics

The authors declare that they have no conflicts of interest related to the contents of this article. Si continua navegando, consideramos que acepta su uso. Today Balkan endemic nephropathy is a disease of the elderly with a good prognosis.

Erythropoietin resistance and survival in non-dialysis patients with stage chronic kidney disease and heart disease. In addition, none of the mentioned factors for Epo hyporesponsiveness were significantly more pronounced in BEN than in non-BEN patients, except for older age. You can change the settings or obtain more information by clicking here. To improve our services and products, we use “cookies” own or third parties authorized to show advertising related to client preferences through the analyses of navigation customer behavior.

  C106B DATASHEET PDF

The Journal publishes articles on basic or clinical research relating to nephrology, arterial hypertension, dialysis and kidney transplants. Ingredient matches for Eritropoyetina Humana Recombinante Delta Erythropoietin Erythropoietin is reported as an ingredient of Eritropoyetina Humana Recombinante Delta in the following countries: The predose plasma recombinabte of erythropoietin Epo was subtracted from all postdose levels.

The study involved 24 hemodialysis patients, 10 patients with BEN and 14 with other kidney diseases, selected from 96 patients 40 BEN and 56 others who met the inclusion criteria.

This finding needs to be confirmed in a well-controlled study with a larger sample size. To recpmbinante our services and products, we use “cookies” own or third parties authorized to show advertising related to client preferences through the analyses of navigation customer behavior.

July Pages All patients were treated thrice weekly for h bystandard bicarbonate hemodialysis using recmobinante membrane dialyzers. The utilization of rHuEp changed definitively the treatment and the natural history of anemia in patients with chronic renal insufficiency CRIand now is modifying the treatment of anemia of other non-renal patients as anemia of premature, anemia in onco-hematological illnesses, anemia in human immunodeficiency virus HIV infection, and for reduction of allogenic blood transfusions in surgery.

Continuing navigation will be considered as acceptance of this use. When adjusted these differences remained statistically significant 0. Br J Clin Pharmacol ; CiteScore measures average citations received per document published. Endemic Balkan Nephropathy, Proc. Nonerythropoietin receptor-mediated pathways may recombinanhe a major role. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal’s impact.

  GENEL KIMYA TEMEL KAVRAMLAR RAYMOND CHANG PDF

There was a problem providing the content you requested

Although an impact of age on Epo elimination in our patients cannot be fully excluded, neither age nor other covariates that differed between the groups was found affect Epo elimination in the ANCOVA model. SRJ is a prestige metric based on the idea that not all citations are the same. Eritropyetina Pharm Sci ; Main characteristics of the patients ACEI: Introduction Anemia was described as a characteristic of Balkan endemic nephropathy BEN in early reports on the disease, 1,2 so Danilovic 3 included it among the criteria for diagnosis.

Subscribe to our Newsletter. Faculty of Pharmacy, University of Belgrade, Serbia.

Eritropoyetina recombinante humana en la insuficiencia renal crónica

Results The study involved 24 hemodialysis patients, 10 patients with BEN and 14 with other kidney diseases, selected from 96 patients 40 BEN and 56 others who met the inclusion criteria. Home Articles in press Archive. J Biol Chem ; Subscribe to free Drugs.

Clin J Am Soc Nephrol ;3: After beta-Epo administration plasma Epo slowly increased and C max was achieved after Population pharmacokinetics of darbepoetin alfa in healthy subjects. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional.

Indicaciones de la eritropoyetina recombinante. Are you a health professional able to prescribe or dispense drugs? Pharmacokinetics and pharmacodynamics of intravenous and subcutaneous continuous erythropoietin receptor activator C.

J Am Soc Nephrol ;